Status:
COMPLETED
TMJ Dysfunction Following Use of SAD
Lead Sponsor:
University Hospitals Coventry and Warwickshire NHS Trust
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Conditions:
Temporomandibular Joint Disorder Bilateral
Eligibility:
All Genders
18-100 years
Brief Summary
The aim of this study is to assess how the use of a breathing tube (Supraglottic Airway Device) can affect the function of the jaw joint (Temporomandibular joint) movement. This type of breathing tube...
Detailed Description
1. INTRODUCTION 1.1 Background Supraglottic airway devices (SADs) are part of the mainstay of anaesthetic practice, being the primary airway management device in 56% of general anaesthetics. SADs are ...
Eligibility Criteria
Inclusion
- • All patients aged above 18, presenting for elective surgical procedure under general anaesthesia, where a supraglottic airway device can be used as primary airway device. This involves a group of patients presenting for day case surgical procedures.
Exclusion
- • Patients under the age of 18
- Patients who do not consent to being part of the study
- Patients in whom SAD is unlikely to be the primary airway device
- If a translator is not available at the time, participants who cannot reasonably read and communicate in English
Key Trial Info
Start Date :
September 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 18 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04103047
Start Date
September 23 2019
End Date
December 18 2020
Last Update
May 7 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham Heartlands Hospital
Birmingham, West Midlands, United Kingdom, B9 5SS
2
University Hospitals Coventry & Warwickshire NHS Trust
Coventry, West Midlands, United Kingdom, CV2 2DX